RHAMNOSE ANTAGONISTS AND USE THEREOF

摘要

The present invention is related to new molecules capable of inhibiting rhamnolipids and especially epithelial infiltration by Gram-negative bacteria. In particular, the invention provides proteins useful in the prevention and/or treatment of Gram-negative bacteria induced infections or disorders, including nosocomial infections.